COMMUNIQUÉS West-GlobeNewswire

VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing
28/04/2026
VivoSim’s NAMkind™ Intestinal Model combined with AI prediction tools yields high-accuracy results SAN DIEGO, April 28, 2026 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider [...]
Jyong Biotech Updates Market Access Strategy for Innovative Botanical Drugs, Establishing Multiple Competitive Advantages for New Drug Portfolio
28/04/2026
New Taipei City, Taiwan, April 28, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization [...]
Plus Therapeutics Secures Blue Shield of California Coverage for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
28/04/2026
Expands access by 6 million covered lives, advancing commercial momentum for CNSide® in metastatic CNS cancers HOUSTON, April 28, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus [...]
Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update
28/04/2026
With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the trial remains on track [...]
Silexion Therapeutics Announces Successful Submission of Phase 2/3 Clinical Trial Application to Germany’s BfArM for SIL204 in KRAS-Driven Locally Advanced Pancreatic Cancer
28/04/2026
CTA submission positions Silexion for European Phase 2/3 trial of SIL204 in KRAS-driven pancreatic cancer, with Germany serving as Reference Member State for the EU program Grand Cayman, Cayman Islands, April 28, 2026 ( [...]
Leadership Team Expansion to Support the Need for Healthier Employees
28/04/2026
TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Employers of all sizes are confronting unprecedented economic and geopolitical pressures that are resulting in crisis levels of employee burnout and mental health challenges. [...]
Playground Pediatrics Expands Pediatric Access Across Four States
28/04/2026
High-quality pediatric care is growing in Georgia, North Carolina, Pennsylvania, and Tennessee NASHVILLE, Tenn., April 28, 2026 (GLOBE NEWSWIRE) -- Playground Pediatrics, a physician-led pediatric primary care services [...]
Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand
28/04/2026
Positioned to Meet Accelerating Travel Activity across New York City, The Hamptons, Nantucket and Martha’s Vineyard Scalable Short-Haul Luxury Aviation Platform Targeting Key Regional Travel Markets FORT MILL, S.C., [...]
Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis
28/04/2026
Oak Ridge, TN, April 28, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces it will exhibit its Blood Volume Analyzer (BVA ™ ) technology [...]
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
28/04/2026
Emergent’s Canton facility will manufacture drug substance and obtains exclusive distribution rights GAITHERSBURG, Md. and GENEVA, April 28, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today [...]
Biomolecular Holdings Announces Issuance of Foundational Patents for Revolutionary Tetrahedral Antibody Technology
28/04/2026
BURLINGAME, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Biomolecular Holdings LLC, a privately-held biotechnology company advancing next-generation antibody architectures, today announced that the United States Patent [...]
Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution
28/04/2026
– ARCALYST ® (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth – – ARCALYST 2026 expected net product revenue increased to $930 - $945 million – – KPL-387 Phase 2 [...]
Cynet Launches New Capabilities for CyAI Engine That Improves Itself Over Time
28/04/2026
New AI capabilities create a feedback loop where analyst input and automated analysis continuously improve threat detection and response BOSTON, April 28, 2026 (GLOBE NEWSWIRE) -- Cynet, the unified, AI-powered [...]
CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation
28/04/2026
Using epigenomic mapping and regulatory RNA (regRNA) Capture-seq, CAMP4 has assembled what it believes to be the largest catalog of regRNAs ever compiled, uncovering thousands of previously undiscovered regRNAs in human [...]
Kestrel Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, in Patients with KRAS-driven Malignancies
28/04/2026
Kestrel has entered into a warrant agreement with AbbVie with an exclusive option for AbbVie to acquire the Company based on defined development milestones WATERTOWN, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Kestrel [...]
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
28/04/2026
Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per batch that is among the lowest in the industry Initial translational data [...]
BridgeBio Launches Health Education Effort on Often Overlooked Heart Condition Featuring Attruby® Advocates, Morgan Freeman and Sports Business Icon Howard H. White
28/04/2026
- New national campaign encourages recognition of ATTR-CM, often mistaken for other heart conditions, where earlier diagnosis and treatment may help improve outcomes 1 PALO ALTO, Calif., April 28, 2026 (GLOBE NEWSWIRE [...]
Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress
28/04/2026
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced nine presentations at the European Society of Cardiology Heart Failure 2026 Congress taking place [...]
Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million
28/04/2026
New acquisitions from Rain Foundation underlines Enlivex’s disciplined prediction markets treasury strategy Nes-Ziona, Israel, April 28, 2026 (GLOBE NEWSWIRE) -- Enlivex Ltd. (Nasdaq: ENLV, “Enlivex” or the “Company”), [...]

Pages